22.02.2024 - Continued Focus on Expanding Product Portfolio, Market Leadership and InnovationSAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) - Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to .
Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific InnovationSAN DIEGO, May 08, 2023 Maravai LifeSciences Holdings, Inc. , a global provider of life science. | May 8, 2023
22.02.2023 - Base business revenues, excluding COVID-19 related CleanCap revenues, were up 67% in the fourth quarter and up 17% for the full year Announces acquisition of privately-held Alphazyme, LLC, adding critical enzyme manufacturing capabilities to .